TITLE

Anticholinergic activity and cognitive decline in Parkinson's disease

AUTHOR(S)
Starkstein, Sergio E.
PUB. DATE
February 2010
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Feb2010, Vol. 81 Issue 2, p129
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In this article, the author discusses the anticholinergic activity and cognitive decrease in Parkinson's disease (PD). He notes that PD patients treated with anticholinergic activity had greater cognitive decline than the patients with PD which were not medicated with those drugs. He points out that the findings is increased by the large sample of the study and the fact that the patients were recruited from community based cohort.
ACCESSION #
48013119

 

Related Articles

  • Drug treatment in Parkinson's disease. Pearce, J.M.S. // British Medical Journal (Clinical Research Edition);6/16/1984, Vol. 288 Issue 6433, p1777 

    Investigates the issue of drugs for the management of Parkinson's disease. Role of anticholinergic drugs in disease intervention; Advantage of the drug amantadine; Importance of confining treatment to no more than two drugs at a time.

  • INITIATING TREATMENT IN EARLY PARKINSON'S DISEASE. Tarsy, Daniel // Johns Hopkins Advanced Studies in Medicine;12/10/2008, Vol. 8 Issue 12, p419 

    Many factors affect the decision to initiate pharmacotherapy for Parkinson's disease (PD), and it is a joint decision among the patient, the physician, and the patient's family. Drug treatment for PD should be individualized for the particular patient. If a medication switch is considered, the...

  • Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study. Ehrt, Uwe; Broich, Karl; Larsen, Jan Petter; Ballard, Clive; Aarsland, Dag // Journal of Neurology, Neurosurgery & Psychiatry;Feb2010, Vol. 81 Issue 2, p160 

    Background Cognitive decline is common in Parkinson's disease (PD). Although some of the aetiological factors are known, it is not yet known whether drugs with anticholinergic activity (AA) contribute to this cognitive decline. Such knowledge would provide opportunities to prevent acceleration...

  • Parkinson's management combines art and science. Petersen, Carolyn // Managed Healthcare;Nov98, Vol. 8 Issue 11, p44 

    Provides information on the treatment anf management of Parkinson's disease. Medications prescribed for the disease; Monitoring and follow up care on the disease; Details on several treatment programs.

  • Pramipexole Is Effective in the Treatment of Early Parkinson's Disease. Rose, Verna L. // American Family Physician;9/15/1999, Vol. 60 Issue 4, p1213 

    Focuses on the effectiveness of pramipexole in the treatment of early Parkinson's disease. Details on the results of the study conducted on the efficacy of pramipexole; Side effects of pramipexole.

  • Treating neuroinflammation: Exploring its potential in Parkinson's disease. Ahmed-Landeryou, Musharrat J. // British Journal of Neuroscience Nursing;Nov2009, Vol. 5 Issue 11, p511 

    Parkinson's disease (PD) is the second most common disease of the ageing brain, Alzheimer's being the first, about 1% of the world's population over the age of 60. PD is a complex disease with many external factors that may influence its pathogenesis. The current focus of PD research is on...

  • benztropine mesilate.  // Royal Society of Medicine: Medicines;2002, p108 

    The article presents information on benztropine mesilate, an anticholinergic drug used in the treatment of some types of parkinsonism. It increases mobility and decreases rigidity and tremor, and the tendency to produce an excess of saliva is also reduced, but it has only a limited effect on...

  • TRIHEXYPHENIDYL HYDROCHLORIDE.  // International Pharmacopoeia: Fourth Edition;2006, Vol. 2, p924 

    A monograph for the pharmaceutical substance "TRIHEXYPHENIDYLI HYDROCHLORIDUM/TRIHEXYPHENIDYL HYDROCHLORIDE" from the fourth edition of "The International Pharmacopoeia" is presented. Trihexyphenidyl hydrochloride is categorized as an anticholinergic or anti-parkinsonism drug and is described as...

  • procyclidine. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p629 

    A definition of the term "procyclidine" is presented. This refers to an anticholinergic drug for the treatment of Parkinson's disease. This drug is also used for reducing the side effects of certain antipsychotic drugs. Side effects of procyclidine include blurred vision and dry mouth.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics